The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatment

@article{Tokunaga2016TheUO,
  title={The utility of tumor marker combination, including serum P53 antibody, in colorectal cancer treatment},
  author={Ryuma Tokunaga and Yasuo Sakamoto and Shigeki Nakagawa and Naoya Yoshida and Hideo Baba},
  journal={Surgery Today},
  year={2016},
  volume={47},
  pages={636-642}
}
Serum P53 antibody (S-P53Ab) is reportedly an effective screening tool for cancer. The aim of this study is to investigate the clinical significance of tumor markers combination in colorectal cancer (CRC) patients. Carcinoembryonic antigen (CEA), carbohydrate 19 - 9 (CA19-9), and S-P53Ab levels were measured before tumor resection. Of the CRC patients with primary tumor resection at Kumamoto University Hospital, a total of 244 with available preoperative data for these three tumor markers were… CONTINUE READING

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 32 references

Hereditary gastrointestinal cancer

Surgery Today • 2015
View 1 Excerpt

p53 as a target for the treatment of cancer.

Cancer treatment reviews • 2014
View 2 Excerpts

Similar Papers

Loading similar papers…